117 results
8-K
EX-10.1
VTRO
Vitro Biopharma, Inc.
17 Apr 24
Entry into a Material Definitive Agreement
5:27pm
agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature of interest shall not exceed … or default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company may be obligated to pay under
8-K
EX-10.1
9ouh6b
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
8-K
EX-10.2
dtb0h m6l4b2u12m8
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
8-K
EX-10.3
33zij8smmqwp12v3b6
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
D
uvha1ub
1 Dec 23
$3.00 mm in debt / options, sold $2.00 mm, 1 investor
10:29am
8-K
EX-10.4
bis6o8m
22 Nov 23
Entry into a Material Definitive Agreement
1:55pm
8-K
EX-10.5
l2w b0xkz
22 Nov 23
Entry into a Material Definitive Agreement
1:55pm
8-K
EX-10.2
sp5iz0p2tk s8f
22 Nov 23
Entry into a Material Definitive Agreement
1:55pm
8-K
EX-10.6
5ggh lwbpu31l2
22 Nov 23
Entry into a Material Definitive Agreement
1:55pm